MAPT and early-onset autosomal dominant Alzheimer disease: However, other research shows an interaction between taurine and L- Dopa in the case of Parkinson’s disease and with Tau protein in the case of Alzheimer’s disease, recommending further studies before its use in patients with these diseases [33,73].